Back to top

Berenberg Bank Reaffirms Their Buy Rating on Vidrala (0NV7)

In a report released yesterday, from Berenberg Bank maintained a Buy rating on Vidrala, with a price target of €110.00. The company’s shares closed...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Vir Biotechnology, Inc. (VIR)